135 related articles for article (PubMed ID: 3828020)
1. Cerebral infarction with a single oral dose of phenylpropanolamine.
Edwards M; Russo L; Harwood-Nuss A
Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020
[TBL] [Abstract][Full Text] [Related]
2. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products.
McEwen J
Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report.
Chung YT; Hung DZ; Hsu CP; Yang DY; Wu TC
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):432-5. PubMed ID: 9699397
[TBL] [Abstract][Full Text] [Related]
4. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review.
Glick R; Hoying J; Cerullo L; Perlman S
Neurosurgery; 1987 Jun; 20(6):969-74. PubMed ID: 2956531
[TBL] [Abstract][Full Text] [Related]
5. Neurological and cardiac events on phenylpropanolamine.
Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819
[TBL] [Abstract][Full Text] [Related]
6. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction.
Pilsczek FH; Karcic AA; Freeman I
Heart Lung; 2003; 32(2):100-4. PubMed ID: 12734532
[TBL] [Abstract][Full Text] [Related]
7. Combining nonprescription medications.
Shuster J
Nursing; 1998 Jun; 28(6):77. PubMed ID: 9668801
[No Abstract] [Full Text] [Related]
8. FDA issues public health advisory on phenylpropanolamine in drug products.
Meadows M
FDA Consum; 2001; 35(1):9. PubMed ID: 11930934
[No Abstract] [Full Text] [Related]
9. Amphetamine-like reactions to phenylpropanolamine.
Dietz AJ
JAMA; 1981 Feb; 245(6):601-2. PubMed ID: 7452888
[TBL] [Abstract][Full Text] [Related]
10. Nonprescription appetite suppressants.
Drew R
N C Med J; 1983 Sep; 44(9):573-4. PubMed ID: 6579375
[No Abstract] [Full Text] [Related]
11. PPA: an innocent over-the-counter drug?
Ludwikowski KL
Pediatr Nurs; 1984; 10(6):387-90. PubMed ID: 6569428
[No Abstract] [Full Text] [Related]
12. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.
Mersfelder TL
Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849
[TBL] [Abstract][Full Text] [Related]
13. Phenylpropanolamine and hemorrhagic stroke.
Ernst ME; Hartz A
N Engl J Med; 2001 Apr; 344(14):1094; author reply 1095. PubMed ID: 11291667
[No Abstract] [Full Text] [Related]
14. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion.
Gilmer G; Swartz M; Teske M; Crandall AS
Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408
[No Abstract] [Full Text] [Related]
15. Phenylpropanolamine and hemorrhagic stroke.
Wolowich WR; Casavant MJ; Ekins BR
N Engl J Med; 2001 Apr; 344(14):1094-5. PubMed ID: 11291666
[No Abstract] [Full Text] [Related]
16. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
[TBL] [Abstract][Full Text] [Related]
17. Cerebral arteritis associated with oral use of phenylpropanolamine: report of a case.
Ryu SJ; Lin SK
J Formos Med Assoc; 1995; 94(1-2):53-5. PubMed ID: 7613235
[TBL] [Abstract][Full Text] [Related]
18. Phenylpropanolamine and intracranial hemorrhage risk in a Mexican population.
Arauz A; Velásquez L; Cantú C; Nader J; López M; Murillo L; Aburto Y
Cerebrovasc Dis; 2003; 15(3):210-4. PubMed ID: 12646782
[TBL] [Abstract][Full Text] [Related]
19. [Cerebral hemorrhage associated with phenylpropanolamine].
Strand OA; Lund-Tønnesen S; Sortland O
Tidsskr Nor Laegeforen; 1991 May; 111(12):1490-2. PubMed ID: 2042180
[TBL] [Abstract][Full Text] [Related]
20. Over-the-counter stroke?
Ornato JP
Health News; 2000 Dec; 6(12):3. PubMed ID: 11142938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
